Press releases
- Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
- Edwards Lifesciences to Sell Critical Care to BD
- Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability
- Edwards Lifesciences Reports First Quarter Results
- Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
- Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
More ▼
Key statistics
As of last trade Edwards Lifesciences Corp (EWL:FRA) traded at 81.51, -8.33% below its 52-week high of 88.92, set on Mar 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 81.51 |
---|---|
High | 81.51 |
Low | 81.51 |
Bid | 81.64 |
Offer | 82.22 |
Previous close | 80.50 |
Average volume | 668.14 |
---|---|
Shares outstanding | 602.60m |
Free float | 597.18m |
P/E (TTM) | 37.42 |
Market cap | 52.47bn USD |
EPS (TTM) | 2.33 USD |
Data delayed at least 15 minutes, as of Jun 10 2024 07:20 BST.
More ▼